Comparison of itraconacole, voriconazole and posaconazole as oral antifungal prophylaxis in paediatric patients following allogeneic stem cell transplantation

被引:0
|
作者
Doering, M. [1 ]
Blume, O. [1 ]
Hartmann, U. [1 ]
Kimmig, A. [1 ]
Schwarze, C. -P. [1 ]
Handgretinger, R. [1 ]
Mueller, I. [2 ]
机构
[1] Univ Childrens Hosp, Tubingen, Germany
[2] Univ Med Ctr, Hamburg, Germany
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S223 / S223
页数:1
相关论文
共 50 条
  • [1] Retrospective Analysis of Itraconacole, Voriconazole and Posaconazole As Oral Antifungal Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation
    Doring, Michaela
    Blume, Olivia
    Haufe, Susanne
    Hartmann, Ulrike
    Kimmig, Astrid
    Schwarze, Carl-Philipp
    Handgretinger, Rupert
    Mueller, Ingo
    BLOOD, 2011, 118 (21) : 1297 - 1297
  • [2] Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation
    Doering, M.
    Blume, O.
    Haufe, S.
    Hartmann, U.
    Kimmig, A.
    Schwarze, C. -P.
    Lang, P.
    Handgretinger, R.
    Mueller, I.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (04) : 629 - 638
  • [3] Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation
    M. Döring
    O. Blume
    S. Haufe
    U. Hartmann
    A. Kimmig
    C.-P. Schwarze
    P. Lang
    R. Handgretinger
    I. Müller
    European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33 : 629 - 638
  • [4] Antifungal prophylaxis with posaconazole in allogeneic stem cell transplantation
    Mele, A.
    De Francesco, R.
    Carlino, D.
    Sibilla, S.
    Fina, M.
    Greco, G.
    Rossini, B.
    Ferrara, P.
    Del Casale, C.
    Morciano, M.
    Ostuni, A.
    Pavone, V.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S229 - S230
  • [5] Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
    Michaela Döring
    Carsten Müller
    Pascal-David Johann
    Annika Erbacher
    Astrid Kimmig
    Carl-Philipp Schwarze
    Peter Lang
    Rupert Handgretinger
    Ingo Müller
    BMC Infectious Diseases, 12
  • [6] Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
    Doering, Michaela
    Mueller, Carsten
    Johann, Pascal-David
    Erbacher, Annika
    Kimmig, Astrid
    Schwarze, Carl-Philipp
    Lang, Peter
    Handgretinger, Rupert
    Mueller, Ingo
    BMC INFECTIOUS DISEASES, 2012, 12
  • [7] Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole?
    M. Hoenigl
    K. Seeber
    R. Krause
    Infection, 2014, 42 : 233 - 234
  • [8] Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole?
    Hoenigl, M.
    Seeber, K.
    Krause, R.
    INFECTION, 2014, 42 (01) : 233 - 234
  • [9] Antifungal prophylaxis with voriconazole in allogeneic hematopoietic stem cell transplantation recipients
    Magalhaes-Silverman, M
    Carter, T
    Hohl, R
    Shamsuddin, H
    Gingrich, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 89 - 89
  • [10] Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
    Marks, David I.
    Pagliuca, Antonio
    Kibbler, Christopher C.
    Glasmacher, Axel
    Heussel, Claus-Peter
    Kantecki, Michal
    Miller, Paul J. S.
    Ribaud, Patricia
    Schlamm, Haran T.
    Solano, Carlos
    Cook, Gordon
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (03) : 318 - 327